IL17A and psoriasis: To determine if IC50 vs IC90 coverage in vivo is required to significantly reduce IL-17-dependent gene expression, a 4-day model of Th17-dependent skin inflammation was developed by modifying the pre-clinical model of imiquimod (IMQ)-induced psoriasis.